{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:20:12Z","timestamp":1741926012338,"version":"3.38.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.endien.2025.501546","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:23:18Z","timestamp":1741868598000},"page":"501546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New drugs in pituitary diseases"],"prefix":"10.1016","volume":"72","author":[{"given":"Fernando","family":"Cordido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2025.501546_bib0115","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","article-title":"Hypopituitarism","volume":"403","author":"Fleseriu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.endien.2025.501546_bib0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/DDDT.S315172","article-title":"Developments in the management of growth hormone deficiency: clinical utility of somapacitan","volume":"18","author":"Miller","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.endien.2025.501546_bib0125","doi-asserted-by":"crossref","first-page":"e1358","DOI":"10.1210\/clinem\/dgaa049","article-title":"Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial","volume":"105","author":"Johannsson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.endonu.2013.01.012","article-title":"Practical guidelines for diagnosis and treatment of acromegaly","volume":"60","author":"Cordido","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endien.2025.501546_bib0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/clinem\/dgae444","article-title":"Personalized medicine in acromegaly: the ACROFAST study","volume":"110","author":"Marques-Pamies","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0140","doi-asserted-by":"crossref","first-page":"e3785","DOI":"10.1210\/clinem\/dgaa526","article-title":"Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide","volume":"105","author":"Samson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0145","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/EJE-22-0220","article-title":"Durable biochemical response and safety with oral octreotide capsules in acromegaly","volume":"187","author":"Samson","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2025.501546_bib0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/17446651.2024.2363540","article-title":"Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use","volume":"19","author":"Fleseriu","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0155","doi-asserted-by":"crossref","first-page":"e1323","DOI":"10.1210\/clinem\/dgad568","article-title":"New treatments for acromegaly in development","volume":"109","author":"Gadelha","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1210\/clinem\/dgae385","article-title":"Acromegaly disease control maintained after switching from injected somatostatin receptor ligands to oral paltusotine","volume":"110","author":"Gadelha","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0165","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1093\/ejendo\/lvae110","article-title":"How to manage Cushing's disease after failed primary pituitary surgery","volume":"191","author":"Agrawal","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2025.501546_bib0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.endien.2025.501546_bib0175","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvae003","article-title":"Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study","author":"Urwyler","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2025.501546_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11060-022-04149-7","article-title":"Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma","volume":"160","author":"Iglesias","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.endien.2025.501546_bib0185","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.endien.2025.501546_bib0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11102-022-01212-4","article-title":"Targeted therapies in the medical management of craniopharyngioma","volume":"25","author":"Iglesias","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.endien.2025.501546_bib0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa2213329","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endien.2025.501546_bib0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/endrev\/bnac035","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endien.2025.501546_bib0205","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1210\/clinem\/dgae503","article-title":"Approach to the patient: new era emerges for craniopharyngioma management","volume":"109","author":"Hayes","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2025.501546_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm13010116","article-title":"Aggressive and metastatic pituitary neuroendocrine tumors: therapeutic management and off-label drug use","volume":"13","author":"Iglesias","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.endien.2025.501546_bib0215","first-page":"321","article-title":"Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide","volume":"49","author":"Dea","year":"2024","journal-title":"Minerva Endocrinol (Torino)"},{"key":"10.1016\/j.endien.2025.501546_bib0220","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgad098","article-title":"Aggressive pituitary tumors and pituitary carcinomas: from pathology to treatment","volume":"108","author":"Burman","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018025000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018025000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:17:31Z","timestamp":1741871851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018025000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2530018025000320"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2025.501546","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New drugs in pituitary diseases","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2025.501546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501546"}}